Kevinkd123-123_123 · Newsroom

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
The pipeline features a variety of candidate drugs that target a wide range of disease-causing / associated proteins; majority of the existing drug candidates are designed for administration via non-invasive routes

January 8, 2021

The “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”
An analysis of the prevalent and emerging trends in this domain, as represented on the social media platform, Twitter, posted during the period 2010-2019 (till May),

January 8, 2021

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers
Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

January 8, 2021

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030
An analysis of recent activity on Twitter confirms the rising interest in this domain as stakeholders attempt to harness the therapeutic potential of synthetic lethality

January 8, 2021

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis
Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit

January 8, 2021